REPORTS

Let’s Pullulate and Expand Your Business

Anticancer Drugs Market - Global Professional Analysis and Forecast to 2026

Mar 13, 2020  |  198 PAGES  |  REPORT CODE: CMM271597
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Anticancer Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.4% during the forecast period.

This report presents the market size and development trends by detailing the Anticancer Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Anticancer Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Anticancer Drugs industry and will help you to build a panoramic view of the industrial development.

Anticancer Drugs Market, By Type:

  • Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)

  • Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)

  • Hormonal Drugs

Anticancer Drugs Market, By Application:

  • Lung Cancer

  • Breast Cancer

  • Leukemia

  • Colorectal Cancer

Some of the leading players are as follows:

  • Pfizer Inc

  • Novartis AG

  • Bayer AG

  • Amgen Inc

  • Eli Lilly and Company

  • AstraZeneca

  • CELGENE CORPORATION

  • F. Hoffmann-La Roche Ltd

  • Merck & Co.

  • Takeda Pharmaceutical Company Limited

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Anticancer Drugs Market: Technology Type Analysis

  • 4.1 Anticancer Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Anticancer Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)

    • 4.3.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)

    • 4.3.3 Hormonal Drugs

5 Anticancer Drugs Market: Product Analysis

  • 5.1 Anticancer Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 Anticancer Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Anticancer Drugs Market: Application Analysis

  • 6.1 Anticancer Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 Anticancer Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Lung Cancer

    • 6.3.2 Breast Cancer

    • 6.3.3 Leukemia

    • 6.3.4 Colorectal Cancer

7 Anticancer Drugs Market: Regional Analysis

  • 7.1 Anticancer Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 Anticancer Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Pfizer Inc

    • 9.1.1 Pfizer Inc Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novartis AG

    • 9.2.1 Novartis AG Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bayer AG

    • 9.3.1 Bayer AG Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Amgen Inc

    • 9.4.1 Amgen Inc Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Eli Lilly and Company

    • 9.5.1 Eli Lilly and Company Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 AstraZeneca

    • 9.6.1 AstraZeneca Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 CELGENE CORPORATION

    • 9.7.1 CELGENE CORPORATION Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 F. Hoffmann-La Roche Ltd

    • 9.8.1 F. Hoffmann-La Roche Ltd Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Merck & Co.

    • 9.9.1 Merck & Co. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Takeda Pharmaceutical Company Limited

    • 9.10.1 Takeda Pharmaceutical Company Limited Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 85 Figures and 126 Tables)

  • Figure Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Anticancer Drugs market, 2015 - 2026 (USD Million)

  • Figure Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Anticancer Drugs market, 2015 - 2026 (USD Million)

  • Figure Hormonal Drugs Anticancer Drugs market, 2015 - 2026 (USD Million)

  • Figure Lung Cancer market, 2015 - 2026 (USD Million)

  • Figure Breast Cancer market, 2015 - 2026 (USD Million)

  • Figure Leukemia market, 2015 - 2026 (USD Million)

  • Figure Colorectal Cancer market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Anticancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe Anticancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Anticancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA Anticancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Anticancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Anticancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Anticancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amgen Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CELGENE CORPORATION Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top